OncoFrontier·Oct 26ESMO 2026: Blood Tests That Track Cancer Response Early, and What They Do Not Yet ProveEarly ctDNA results from ESMO 2026 show a blood test can track response, but it is not yet proven to guide treatment.
Peter Friebe·Oct 13Can a blood test screen for more than 50 types of cancer? Understanding GalleriDisclosure: I wrote this article and used AI as a “professional editor” to refine and shorten overly long or complicated sentences.
Peter Friebe·Aug 18Liquid biopsy versus colonoscopy: which one is better for colorectal cancer screening?Disclosure: I wrote this article and used AI as a “professional editor” to refine and shorten overly long or complicated sentences. .
Ashish Yadav·Jul 7Liquid Biopsy: From Research Tool to Regulated Clinical Diagnostic — What the Transition RequiresThe Liquid Biopsy Transition Moment
Peter Friebe·Mar 4Understanding Liquid BiopsyDisclosure: I wrote this article and used AI as a “professional editor” to refine and shorten overly long or complicated sentences.
Shamitha Attur·Oct 15, 2025BEYOND THE PINK RIBBON: THE SHIFTER BIOLOGY AND EARLY DETECTION PRIORITY IN BREAST CANCEREach October, we’re inundated with pink ribbons — icons of hope, survival, and activism. But behind the color of consensus lies a much…
Azra Butt·Oct 26, 2024Liquid Biopsy: Revolutionizing Cancer DiagnosticsCancer probably emerges as one of the most destructive diseases threatening humankind today. It has been proclaimed one of the greatest…A response icon12A response icon12
International Youth STEM Society·Apr 7, 2024Liquid Biopsies for Cancer DiagnosisLiquid biopsies have emerged as a revolutionary approach for non-invasive cancer diagnosis and monitoring, offering unprecedented…
Pierre Arsène·Jan 27, 2024GRAIL Divestment: Perspectives, Valuation and its Potential Impact on the Liquid Biopsy Field (2/2)Returning from #JPM24, this post is a continuation from my previous post where I provided background on GRAIL’s situation and discussed its…
OncoDxRx·Dec 28, 2023Potential New Lung Cancer Treatment Uncovered Using OncoDxRx’s PGA PlatformScientists at OncoDxRx have unveiled a class of drug known as Avagacestat as a promising new target for future lung cancer treatments using…